ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

MCRB Seres Therapeutics Inc

0.99
0.016 (1.64%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Seres Therapeutics Inc MCRB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.016 1.64% 0.99 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.99 0.98 1.07 1.00 0.974
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/5/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202419:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202419:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202409:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202406:05EDGAR2Form 8-K - Current report
08/5/202406:00BWSeres Therapeutics Reports First Quarter 2024 Financial..
07/5/202416:18EDGAR2Form 8-K - Current report
06/5/202415:01BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
06/5/202408:30BWSeres Therapeutics to Announce First Quarter 2024 Financial..
09/4/202406:00BWSeres Therapeutics Announces Completion of Patient..
28/3/202406:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
19/3/202406:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
05/3/202409:18EDGAR2Form DEF 14A - Other definitive proxy statements
05/3/202409:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202406:05EDGAR2Form 8-K - Current report
05/3/202406:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202405:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28/2/202406:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
27/2/202406:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
26/2/202406:06EDGAR2Form 8-K - Current report
26/2/202406:00BWSeres Therapeutics Announces the Appointment of Marella..
23/2/202415:05EDGAR2Form PRE 14A - Other preliminary proxy statements
16/2/202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202420:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202420:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:01EDGAR2Form 8-K - Current report
17/1/202406:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10/1/202406:00EDGAR2Form 8-K - Current report
09/1/202407:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
09/1/202406:05EDGAR2Form 8-K - Current report
09/1/202406:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
04/1/202415:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
02/1/202415:05EDGAR2Form 8-K - Current report
07/12/202318:46BWSeres Therapeutics Announces Presentation of Preliminary..
28/11/202308:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
27/11/202318:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202305:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202306:05EDGAR2Form 8-K - Current report
02/11/202306:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
01/11/202309:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
31/10/202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202320:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202320:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock